• Sign In
  • Register
  • Glossary
  • Share/Bookmark
  • RSS
All About Bleeding

Factor IX

This Global website is not intended to represent or suggest that particular products are approved or authorized in any particular jurisdiction. You should not construe anything on this website as a promotion or solicitation for any product or service, or as suggesting that a product or service be used where it is not approved or authorized by applicable law and regulation in a particular country, territory, or jurisdiction. To learn which products are approved or authorized in particular countries, please consult the appropriate country-specific website.

Factor Products

Coagulation therapy is the foundation of CSL Behring’s broad range of therapies.

Learn More

Novel Recombinant Hemophilia Treatments

CSL Behring’s recombinant factor development pipeline is built on its strength in protein research and development and scientific expertise in bleeding disorders

Learn more

Indications

Factor IX concentrates are indicated in bleeding patients with hemophilia B (congenital factor IX deficiency).26 They are used to manage acute bleeding or decrease the risk of bleeding associated with surgery.

 

Learn more about Mononine ®, human coagulation factor IX

Registration status and indications vary from country to country. Please contact your local CSL Behring representative and review the respective prescribing information before considering using a Factor IX concentrate.

 

 

 

 

 

 


Last Updated: 10/15/2015 3:43 PM
  • E-mail
  • Print
  • Share